3i and SEB Företagsinvest, alongside other shareholders, are divesting their stakes in SBL Vaccines, a Swedish vaccine distributor in a sale to NASDAQ listed Dutch biotechnology company Crucell. The sale price is EUR 39.4m, excluding deferred payments and future royalties. It is expected that the transaction will be completed on 23 November.
Investindustrial sells its remaining stake of 4.12% in the company, fully exiting the investment
Following the deal, CCV Schweiz will be integrated with Concardis Schweiz, which is part of Nets Group
Minority shareholder IMS Capital has also filed for insolvency; Getnow is now seeking new investors
Exit from Rutland Fund III realises a return of 5.7x on the original cost of the investment